NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO)

CUSIP: 66737P600

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
2,976,111
Share change
-238,405
Total reported value
$1,689,679
Price per share
$0.57
Number of holders
10
Value change
-$167,500
Number of buys
2
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 66737P600?
CUSIP 66737P600 identifies NWBO - NORTHWEST BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) as of Q2 2023

As of 30 Jun 2023, NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,976,111 shares. The largest 10 holders included Sentinus, LLC, Moloney Securities Asset Management, LLC, Opus Capital Group, LLC, Williams Jones Wealth Management, LLC., MAI Capital Management, LEE DANNER & BASS INC, AlphaMark Advisors, LLC, ADVISORS MANAGEMENT GROUP INC /ADV, Bartlett & Co. LLC, and BARTLETT & CO. WEALTH MANAGEMENT LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.